Home › Compare › CHNXF vs STAG

CHNXF vs STAG: Dividend Comparison 2026

CHNXF yields 26490.07% · STAG yields 3.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHNXF wins by $856500661636595056640.00M in total portfolio value
10 years
CHNXF
CHNXF
● Live price
26490.07%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$856500661636595056640.00M
Annual income
$850,187,174,759,804,400,000,000,000.00
Full CHNXF calculator →
STAG
STAG Industrial Inc.
● Live price
3.44%
Share price
$36.09
Annual div
$1.24
5Y div CAGR
0.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18.3K
Annual income
$462.22
Full STAG calculator →

Portfolio growth — CHNXF vs STAG

📍 CHNXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHNXFSTAG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHNXF + STAG cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CHNXF pays
STAG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHNXF
Annual income on $10K today (after 15% tax)
$2,251,655.63/yr
After 10yr DRIP, annual income (after tax)
$722,659,098,545,833,800,000,000,000.00/yr
STAG
Annual income on $10K today (after 15% tax)
$292.45/yr
After 10yr DRIP, annual income (after tax)
$392.89/yr
At 15% tax rate, CHNXF beats the other by $722,659,098,545,833,800,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHNXF + STAG for your $10,000?

CHNXF: 50%STAG: 50%
100% STAG50/50100% CHNXF
Portfolio after 10yr
$428250330818297528320.00M
Annual income
$425,093,587,379,902,200,000,000,000.00/yr
Blended yield
99.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on STAG right now

CHNXF
No analyst data
Altman Z
-135.2
Piotroski
2/9
STAG
Analyst Ratings
9
Buy
9
Hold
3
Sell
Consensus: Buy
Price Target
$45.00
+24.7% upside vs current
Range: $39.00 — $59.00
Altman Z
1.2
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHNXF buys
0
STAG buys
0
No recent congressional trades found for CHNXF or STAG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHNXFSTAG
Forward yield26490.07% ✓3.44%
Annual dividend / share$2.00 ✓$1.24
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0.3% ✓
Portfolio after 10y$856500661636595056640.00M ✓$18.3K
Annual income after 10y$850,187,174,759,804,400,000,000,000.00 ✓$462.22
Total dividends collected$856084953147245199360.00M ✓$4.0K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: CHNXF vs STAG ($10,000, DRIP)

YearCHNXF PortfolioCHNXF Income/yrSTAG PortfolioSTAG Income/yrGap
1← crossover$2,659,707$2,649,006.62$10,665$345.09+$2.65M → CHNXF
2$661,311,349$658,465,463.27$11,364$357.70+$661.30M → CHNXF
3$153,718,184,329$153,010,581,185.41$12,098$370.43+$153718.17M → CHNXF
4$33,404,167,863,182$33,239,689,405,949.67$12,869$383.28+$33404167.85M → CHNXF
5$6,786,439,075,574,744$6,750,696,615,961,140.00$13,677$396.23+$6786439075.56M → CHNXF
6$1,289,019,706,709,597,000$1,281,758,216,898,732,000.00$14,524$409.27+$1289019706709.58M → CHNXF
7$228,909,915,433,776,940,000$227,530,664,347,597,670,000.00$15,411$422.41+$228909915433776.94M → CHNXF
8$38,007,474,205,860,660,000,000$37,762,540,596,346,516,000,000.00$16,339$435.61+$38007474205860656.00M → CHNXF
9$5,900,455,025,037,820,000,000,000$5,859,787,027,637,549,000,000,000.00$17,311$448.89+$5900455025037819904.00M → CHNXF
10$856,500,661,636,595,100,000,000,000$850,187,174,759,804,400,000,000,000.00$18,327$462.22+$856500661636595056640.00M → CHNXF

CHNXF vs STAG: Complete Analysis 2026

CHNXF — Stock

ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.

Full CHNXF Calculator →

STAG — REIT

STAG Industrial, Inc. (NYSE: STAG) is a real estate investment trust focused on the acquisition and operation of single-tenant, industrial properties throughout the United States. By targeting this type of property, STAG has developed an investment strategy that helps investors find a powerful balance of income plus growth.

Full STAG Calculator →
📬

Get this CHNXF vs STAG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHNXF vs SCHDCHNXF vs JEPICHNXF vs OCHNXF vs KOCHNXF vs MAINCHNXF vs PLDCHNXF vs EQRCHNXF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.